
Bakuchiol: May modestly improve fine lines and uneven pigmentation. Polyhydroxy Acids: Offers exfoliation through ingredients such as gluconolactone and lactobionic acid.


Consider for cosmetic photoaging when retinol is uncomfortable; evidence is smaller.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
Can you use both?
A gentle pairing for sensitive skin: PHAs exfoliate lightly, bakuchiol smooths.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Influences cell signaling: Experimental effects overlap some retinoid pathways. May improve photoaging signs: Small clinical studies suggest benefit.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens surface cells: PHAs promote shedding in the outer skin. Helps bind water: Hydroxyl groups contribute to water binding.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
0.5% bakuchiol cream has been studied for photoaging. This does not make it percentage-equivalent to retinol or establish a best strength for every bakuchiol product.
0.5%
Studied bakuchiol cream
A small randomized trial compared a specific bakuchiol cream with retinol. The study used different application schedules.
Choosing a strength: Choose a finished formula with clear labeling. Bakuchiol content and whole-plant extract content are not the same thing.
Higher strengths: Stronger marketed percentages are not established as more effective. A natural origin does not rule out irritation or allergy.
Formula matters: Do not compare bakuchiol and retinol by matching numbers. Product base, dosing schedule and ingredient identity differ.
PHA is a family name, not one ingredient or one standard strength. A clinical acne trial used 14% gluconolactone; that result cannot be transferred directly to lactobionic acid or mixed-PHA products.
14%
Studied gluconolactone lotion
An older controlled acne trial tested this specific formula. It does not establish the best percentage for all PHA skincare.
Choosing a strength: Check which PHA is listed, whether the product stays on or washes off, and whether it also contains other exfoliating acids.
Higher strengths: A PHA product can still irritate, particularly when combined with other acids. A high total-acid percentage is not a validated benefit rating.
Formula matters: The individual acid, acidity and base formula matter. A blended-acid percentage does not reveal the amount of each PHA.
Approximate windows, not promises.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
May still irritate or trigger a rash; botanical origin does not guarantee tolerance.
Can still sting or cause a rash; sensitive skin does not guarantee tolerance.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Marketed that way, but there is very little safety data, and plant origin is not evidence. Ask the doctor managing your pregnancy. Azelaic acid is the ingredient with an actual record in pregnancy.
Low-strength leave-on acids are generally considered acceptable; ask the clinician managing your pregnancy.
On the skin. The finished product delivers bakuchiol in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Shows retinoid-like effects in experimental models but is not converted into retinoic acid.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers polyhydroxy acids in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. PHA ingredients promote surface exfoliation and may also bind water; individual acids and formulas differ.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider for cosmetic photoaging when retinol is uncomfortable; evidence is smaller.
A 44-person trial compared twice-daily bakuchiol with once-daily retinol without a vehicle arm. No significant difference is not proof of equal efficacy or equal long-term safety.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
A 150-person trial tested 14% gluconolactone for acne. Evidence from that molecule or a mixed-acid serum does not establish identical effects for all PHAs.
Sources